137 related articles for article (PubMed ID: 8566149)
1. G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, inhibits tumor necrosis factor-alpha biosynthesis.
Altavilla D; Squadrito F; Canale P; Ioculano M; Squadrito G; Campo GM; Serranò M; Sardella A; Urna G; Spignoli G
Eur J Pharmacol; 1995 Nov; 286(1):31-9. PubMed ID: 8566149
[TBL] [Abstract][Full Text] [Related]
2. Selective thromboxane synthetase inhibition by picotamide and effects on endotoxin-induced lethality.
Matera G; Chisari M; Altavilla D; Foca A; Cook JA
Proc Soc Exp Biol Med; 1988 Jan; 187(1):58-61. PubMed ID: 3277192
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, in splanchnic artery occlusion shock.
Squadrito F; Altavilla D; Zingarelli B; Ioculano MP; Campo GM; Calapai G; Saitta A; Urna G; Sardella A; Spignoli G
J Cardiovasc Pharmacol; 1992 Jan; 19(1):115-9. PubMed ID: 1375677
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of BAY U 3405, a thromboxane A2 receptor antagonist, in endotoxin shock.
Altavilla D; Canale P; Squadrito F; Sardella A; Ammendolia L; Urna G; Ioculano M; Squadrito G; Caputi AP
Pharmacol Res; 1994; 30(2):137-51. PubMed ID: 7816742
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tumour necrosis factor and reversal of endotoxin-induced shock by U-83836E, a 'second generation' lazaroid in rats.
Altavilla D; Squadrito F; Serrano M; Campo GM; Squadrito G; Arlotta M; Urna G; Sardella A; Saitta A; Caputi AP
Br J Pharmacol; 1998 Jul; 124(6):1293-9. PubMed ID: 9720803
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of UK 37248, a thromboxane synthetase inhibitor, in experimental endotoxic shock in the rat.
Halushka PV; Cook JA; Wise WC
Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):133S-139S. PubMed ID: 6337604
[TBL] [Abstract][Full Text] [Related]
7. Effects of a pyridine derivative thromboxane synthetase inhibitor and its inactive isomer in endotoxic shock in the rat.
Anderegg K; Anzeveno P; Cook JA; Halushka PV; McCarthy J; Wagner E; Wise WC
Br J Pharmacol; 1983 Apr; 78(4):725-32. PubMed ID: 6687819
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of tyrphostin AG-556 on shock induced by endotoxin or gram positive bacteria.
Ogura S; Umegaki O; Genovese F; Fernando LP; Cochran JB; Romeo CM; Cook JA
Shock; 1999 Aug; 12(2):105-10. PubMed ID: 10446890
[TBL] [Abstract][Full Text] [Related]
9. Studies on the beneficial effects of aspirin in endotoxic shock. Relationship to inhibition of arachidonic acid metabolism.
Halushka PV; Wise WC; Cook JA
Am J Med; 1983 Jun; 74(6A):91-6. PubMed ID: 6687979
[TBL] [Abstract][Full Text] [Related]
10. G619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, reduces myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion in rats.
Squadrito F; Ioculano M; Altavilla D; Zingarelli B; Canale P; Campo GM; Saitta A; Oriti S; Spignoli G; Caputi AP
Pharmacology; 1993 Sep; 47(3):167-75. PubMed ID: 8415867
[TBL] [Abstract][Full Text] [Related]
11. Endotoxin-induced procoagulant activity, eicosanoid synthesis, and tumor necrosis factor production by rat peritoneal macrophages: effect of endotoxin tolerance and glucan.
Moore JN; Cook JA; Morris DD; Halushka PV; Wise WC
Circ Shock; 1990 Jul; 31(3):281-95. PubMed ID: 2113440
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of trans-13-APT, a thromboxane receptor antagonist, in endotoxemia.
Olanoff LS; Cook JA; Eller T; Knapp DR; Halushka PV
J Cardiovasc Pharmacol; 1985; 7(1):114-20. PubMed ID: 2580129
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of BAY u3405, a novel thromboxane A2 receptor antagonist, in splanchnic artery occlusion shock.
Canale P; Squadrito F; Altavilla D; Ioculano M; Campo GM; Squadrito G; Urna G; Sardella A; Caputi AP
Pharmacology; 1994 Dec; 49(6):376-85. PubMed ID: 7878075
[TBL] [Abstract][Full Text] [Related]
14. [Experimental study on the pathophysiology of endotoxin shock as analysed by alterations in thromboxane B2 and 6-keto-PGF1 alpha levels].
Baba H
Nihon Geka Gakkai Zasshi; 1988 Jan; 89(1):6-20. PubMed ID: 3283521
[TBL] [Abstract][Full Text] [Related]
15. Effects of ridogrel, a thromboxane synthase inhibitor and receptor antagonist, on blood pressure in the spontaneously hypertensive rat.
Quest DW; Wilson TW
Jpn J Pharmacol; 1998 Dec; 78(4):479-86. PubMed ID: 9920205
[TBL] [Abstract][Full Text] [Related]
16. Elevated thromboxane levels in the rat during endotoxic shock: protective effects of imidazole, 13-azaprostanoic acid, or essential fatty acid deficiency.
Cook JA; Wise WC; Halushka PV
J Clin Invest; 1980 Jan; 65(1):227-30. PubMed ID: 7350199
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of nuclear factor-kappaB activation by IRFI 042, protects against endotoxin-induced shock.
Altavilla D; Squadrito G; Minutoli L; Deodato B; Bova A; Sardella A; Seminara P; Passaniti M; Urna G; Venuti SF; Caputi AP; Squadrito F
Cardiovasc Res; 2002 Jun; 54(3):684-93. PubMed ID: 12031715
[TBL] [Abstract][Full Text] [Related]
18. The lazaroid, U-74389G, inhibits inducible nitric oxide synthase activity, reverses vascular failure and protects against endotoxin shock.
Altavilla D; Squadrito F; Campo GM; Squadrito G; Arlotta M; Urna G; Sardella A; Quartarone C; Saitta A; Caputi AP
Eur J Pharmacol; 1999 Mar; 369(1):49-55. PubMed ID: 10204681
[TBL] [Abstract][Full Text] [Related]
19. Implications for thromboxane A2 in the pathogenesis of endotoxic shock.
Wise WC; Cook JA; Halushka PV
Adv Shock Res; 1981; 6():83-91. PubMed ID: 6961767
[TBL] [Abstract][Full Text] [Related]
20. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.
Yui Y; Hattori R; Takatsu Y; Nakajima H; Wakabayashi A; Kawai C; Kayama N; Hiraku S; Inagawa T; Tsubojima M
Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
